IGF-1 LR3 is sold for laboratory, research, or analytical purposes only not for human consumption, veterinary use, or medical applications
0.3 mL / 30-unit barrels suit the draw volumes in this schedule
26 weeks 182 syringes 1 syringe per injection
Consult the Safety Data Sheet for full handling guidance
The First Two Weeks In the initial phase of utilizing an IGF variant, the most striking and immediate change reported is a dramatic shift in how your body handles carbohydrates
As the body's master antioxidant, glutathione supports cellular detoxification, immune function, oxidative stress reduction, and skin health when delivered through intramuscular or subcutaneous injection